UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Maximizing credit card point value can lead to incredible benefits. Discover effective strategies to boost your rewards potential.
25,565 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Factory construction and investment are rising rapidly, fueling talk of a manufacturing renaissance. Yet a wide gap b...
As AI infrastructure spending accelerates, legendary short seller chanos cautions that the rally could follow a dot-c...
With SPY's yield hovering near 1% and valuations high, investors are turning to covered calls to generate cash flow. ...
A ChatGPT-based forecast tied to Sam Altman envisions Bitcoin rising to $125K by end-2026, with a potential surge to ...
A FormFactor director recently sold 3,000 shares in a move that drew attention from investors. This article breaks do...
XRP’s on-chain activity jumped to about 2.75 million daily transactions, while the token’s price stayed stubbornly ra...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
NVIDIA posted a strong quarterly topline as AI-driven demand pushes data-center sales higher, but a single supply con...
A fresh AI-driven rally has investors buzzing about Alphabet. This article breaks down why alphabet stock popped toda...
Anthropic operates under a rare governance structure: Dario Amodei oversees the company with a single direct report, ...
Dormant Ethereum addresses moved more than 33,600 ETH, revealing a test of demand around the $1,500 level as ethereum...